메뉴 건너뛰기




Volumn 18, Issue 2, 2014, Pages 187-195

Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)

Author keywords

AWARE; Ceftaroline; Latin America

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFTAROLINE; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN; BETA LACTAMASE; EXTENDED SPECTRUM BETA LACTAMASE;

EID: 84897640049     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.11.005     Document Type: Article
Times cited : (20)

References (22)
  • 1
    • 84897657812 scopus 로고    scopus 로고
    • Teflaro® Package Insert. Available at: [accessed August 2013].
    • Teflaro® Package Insert 2012. Available at: [accessed August 2013]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200327s009lbl.pdf.
    • (2012)
  • 2
    • 84897613107 scopus 로고    scopus 로고
    • European Medicines Assessment Report for Zinforo (ceftaroline fosamil) Procedure No. EMEA/H/C/002252.
    • European Medicines Assessment Report for Zinforo (ceftaroline fosamil) Procedure No. EMEA/H/C/002252.
  • 4
    • 79954568574 scopus 로고    scopus 로고
    • Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia
    • iii53-iii59
    • Rank D.R., Friedland H.D., Laudano J.B. Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia. J Antimicrob Chemother 2011, 66:iii53-iii59.
    • (2011) J Antimicrob Chemother , vol.66
    • Rank, D.R.1    Friedland, H.D.2    Laudano, J.B.3
  • 5
    • 78649489951 scopus 로고    scopus 로고
    • CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
    • iv41-iv51
    • Corey G.R., Wilcox M.H., Talbot G.H. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother 2010, 65(Suppl. 4):iv41-iv51.
    • (2010) J Antimicrob Chemother , vol.65 , Issue.SUPPL. 4
    • Corey, G.R.1    Wilcox, M.H.2    Talbot, G.H.3
  • 6
    • 77955957827 scopus 로고    scopus 로고
    • Integrated analysis of CANVAS 1 and 2: Phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection
    • Corey G.R., Wilcox M., Talbot G.H., et al. Integrated analysis of CANVAS 1 and 2: Phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection. Clin Infect Dis 2010, 51:641-650.
    • (2010) Clin Infect Dis , vol.51 , pp. 641-650
    • Corey, G.R.1    Wilcox, M.2    Talbot, G.H.3
  • 7
    • 78649452602 scopus 로고    scopus 로고
    • Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity
    • iv9-iv16
    • Biek D., Critchley I.A., Riccobene T.A., Thye D.A. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity. J Antimicrob Chemother 2010, 65(Suppl. 4):iv9-iv16.
    • (2010) J Antimicrob Chemother , vol.65 , Issue.SUPPL. 4
    • Biek, D.1    Critchley, I.A.2    Riccobene, T.A.3    Thye, D.A.4
  • 8
    • 79954581843 scopus 로고    scopus 로고
    • Ceftaroline fosamil: a new broad-spectrum cephalosporin
    • iii11-iii18
    • Laudano J.B. Ceftaroline fosamil: a new broad-spectrum cephalosporin. J Antimicrob Chemother 2011, 66(Suppl. 3):iii11-iii18.
    • (2011) J Antimicrob Chemother , vol.66 , Issue.SUPPL. 3
    • Laudano, J.B.1
  • 9
    • 79954578994 scopus 로고    scopus 로고
    • Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study
    • iii69-iii80
    • Jones R.N., Farrell D.J., Mendes R.E., Sader H.S. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study. J Antimicrob Chemother 2011, 66(Suppl. 3):iii69-iii80.
    • (2011) J Antimicrob Chemother , vol.66 , Issue.SUPPL. 3
    • Jones, R.N.1    Farrell, D.J.2    Mendes, R.E.3    Sader, H.S.4
  • 10
    • 84861162170 scopus 로고    scopus 로고
    • Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program
    • Flamm R.K., Sader H.S., Farrell D.J., Jones R.N. Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program. Antimicrob Agents Chemother 2012, 56:2933-2940.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 2933-2940
    • Flamm, R.K.1    Sader, H.S.2    Farrell, D.J.3    Jones, R.N.4
  • 11
    • 84865246903 scopus 로고    scopus 로고
    • In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE surveillance program (2008-2010)
    • Farrell D.J., Castanheira M., Mendes R.E., Sader H.S., Jones R.N. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE surveillance program (2008-2010). Clin Infect Dis 2012, 55(Suppl. 3):S206-S214.
    • (2012) Clin Infect Dis , vol.55 , Issue.SUPPL. 3
    • Farrell, D.J.1    Castanheira, M.2    Mendes, R.E.3    Sader, H.S.4    Jones, R.N.5
  • 12
    • 84865210377 scopus 로고    scopus 로고
    • AWARE ceftaroline surveillance program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States
    • Pfaller M.A., Farrell D.J., Sader H.S., Jones R.N. AWARE ceftaroline surveillance program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Clin Infect Dis 2012, 55(Suppl. 3):S187-S193.
    • (2012) Clin Infect Dis , vol.55 , Issue.SUPPL. 3
    • Pfaller, M.A.1    Farrell, D.J.2    Sader, H.S.3    Jones, R.N.4
  • 13
    • 84865218844 scopus 로고    scopus 로고
    • Activity analyses of staphylococcal isolates from pediatric, adult and elderly patients: AWARE ceftaroline surveillance program
    • Sader H.S., Flamm R.K., Farrell D.J., Jones R.N. Activity analyses of staphylococcal isolates from pediatric, adult and elderly patients: AWARE ceftaroline surveillance program. Clin Infect Dis 2012, 55(Suppl. 3):S181-S186.
    • (2012) Clin Infect Dis , vol.55 , Issue.SUPPL. 3
    • Sader, H.S.1    Flamm, R.K.2    Farrell, D.J.3    Jones, R.N.4
  • 17
    • 84897671375 scopus 로고    scopus 로고
    • Tygacil Package Insert. 2011. Wyeth Pharmaceuticals. Available at: [accessed January 2013].
    • Tygacil Package Insert. 2011. Wyeth Pharmaceuticals. Available at: [accessed January 2013]. http://www.tygacil.com/.
  • 18
    • 79956304769 scopus 로고    scopus 로고
    • In vitro activity of ceftaroline against Gram-positive and Gram-negative pathogens isolated from patients attending Canadian hospitals in 2009
    • Karlowsky J.A., Adam H.J., Decorby M.R., Lagace-Wiens P.R., Hoban D.J., Zhanel G.G. In vitro activity of ceftaroline against Gram-positive and Gram-negative pathogens isolated from patients attending Canadian hospitals in 2009. Antimicrob Agents Chemother 2011, 55:2837-2846.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 2837-2846
    • Karlowsky, J.A.1    Adam, H.J.2    Decorby, M.R.3    Lagace-Wiens, P.R.4    Hoban, D.J.5    Zhanel, G.G.6
  • 19
    • 84875372745 scopus 로고    scopus 로고
    • Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010)
    • Farrell D.J., Flamm R.K., Sader H.S., Jones R.N. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010). Int J Antimicrob Agents 2013, 41:337-342.
    • (2013) Int J Antimicrob Agents , vol.41 , pp. 337-342
    • Farrell, D.J.1    Flamm, R.K.2    Sader, H.S.3    Jones, R.N.4
  • 20
    • 84879953414 scopus 로고    scopus 로고
    • Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia
    • Frampton J.E. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia. Drugs 2013, 73:1067-1094.
    • (2013) Drugs , vol.73 , pp. 1067-1094
    • Frampton, J.E.1
  • 21
    • 84865424472 scopus 로고    scopus 로고
    • Activity of ceftaroline-avibactam tested against gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types
    • Castanheira M., Sader H.S., Farrell D.J., Mendes R.E., Jones R.N. Activity of ceftaroline-avibactam tested against gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types. Antimicrob Agents Chemother 2012, 56:4779-4785.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 4779-4785
    • Castanheira, M.1    Sader, H.S.2    Farrell, D.J.3    Mendes, R.E.4    Jones, R.N.5
  • 22
    • 77953479908 scopus 로고    scopus 로고
    • Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America
    • Rodriguez-Noriega E., Seas C., Guzman-Blanco M., et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis 2010, 14:e560-e566.
    • (2010) Int J Infect Dis , vol.14
    • Rodriguez-Noriega, E.1    Seas, C.2    Guzman-Blanco, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.